Showing results (71-80 of 152) with videos related to
Sort By:
Pageof 16
Immunotherapy Advances|September 20, 2021
Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitorsZsofia D Drobni, Sean P Murphy, Raza M Alvi, et al.Immunotherapy Advances|August 15, 2022
CorrectionImmunotherapy Advances|October 21, 2022
Orally administered antigen can reduce or exacerbate pathology in an animal model of inflammatory arthritis dependent upon the timing of administrationGavin R Meehan, Hannah E Scales, Iain B McInnes, et al.Immunotherapy Advances|October 26, 2022
Targeting the high affinity receptor, FcγRI, in autoimmune disease, neuropathy, and cancerTosca Holtrop, Kevin Budding, Arianne M Brandsma, et al.Immunotherapy Advances|October 26, 2022
DNAM1 and TIGIT balance the T cell response, with low T cell TIGIT expression corresponding to inflammation in psoriatic diseaseMarleen E Jacobs, Juliëtte N Pouw, Michel A Olde Nordkamp, et al.Immunotherapy Advances|April 18, 2022
New and emerging concepts and therapies for the treatment of food allergyDavid W Hwang, Cathryn R Nagler, Christina E CiaccioImmunotherapy Advances|February 14, 2022
100 years post-insulin: immunotherapy as the next frontier in type 1 diabetesJames A Pearson, Eoin F McKinney, Lucy S K WalkerImmunotherapy Advances|April 21, 2023
A systems approach evaluating the impact of SARS-CoV-2 variant of concern mutations on CD8+ T cell responsesPaul R Buckley, Chloe H Lee, Agne Antanaviciute, et al.Immunotherapy Advances|April 21, 2023
Combination CD200R/PD-1 blockade in a humanised mouse modelMartin Fellermeyer, Consuelo Anzilotti, Christopher Paluch, et al.Immunotherapy Advances|June 27, 2025
Regulatory B cells promote the immunosuppressive microenvironment and progression of clear cell renal cell carcinomaQintao Ge, Siqi Zhou, Jiahe Lu, et al.Pageof 16